Management of stroke in neonates and children: a scientific statement from the American Heart Association/American Stroke Association

DM Ferriero, HJ Fullerton, TJ Bernard, L Billinghurst… - Stroke, 2019 - Am Heart Assoc
Purpose—Much has transpired since the last scientific statement on pediatric stroke was
published 10 years ago. Although stroke has long been recognized as an adult health …

The genetic basis of moyamoya disease

R Mertens, M Graupera, H Gerhardt, A Bersano… - Translational stroke …, 2022 - Springer
Moyamoya disease (MMD) is a rare cerebrovascular disease characterized by progressive
spontaneous bilateral occlusion of the intracranial internal cerebral arteries (ICA) and their …

Childhood stroke

PB Sporns, HJ Fullerton, S Lee, H Kim, WD Lo… - Nature Reviews …, 2022 - nature.com
Stroke is an important cause of neurological morbidity in children; most survivors have
permanent neurological deficits that affect the remainder of their life. Stroke in childhood, the …

[HTML][HTML] The pathophysiology of moyamoya disease: an update

OY Bang, M Fujimura, SK Kim - Journal of stroke, 2016 - ncbi.nlm.nih.gov
Moyamoya disease (MMD) is a unique cerebrovascular disease characterized by the
progressive stenosis of large intracranial arteries and a hazy network of basal collaterals …

[HTML][HTML] Epidemiology, diagnosis and treatment of moyamoya disease

H Zhang, L Zheng, L Feng - Experimental and …, 2019 - spandidos-publications.com
Moyamoya disease (MMD) is a type of chronic cerebrovascular occlusion disease, which
frequently occurs in East Asian populations, including pediatric and adult patients, and may …

The AAA+ ATPase/ubiquitin ligase mysterin stabilizes cytoplasmic lipid droplets

M Sugihara, D Morito, S Ainuki, Y Hirano… - Journal of Cell …, 2019 - rupress.org
Mysterin, also known as RNF213, is an intracellular protein that forms large toroidal
oligomers. Mysterin was originally identified in genetic studies of moyamoya disease (MMD) …

Moyamoya disease

M Fujimura, OY Bang, JS Kim - … : Pathophysiology, Diagnosis and …, 2016 - karger.com
Moyamoya disease (MMD) is a chronic occlusive cerebrovascular disease characterized by
progressive stenosis at the terminal portion of the internal carotid artery and an abnormal …

Moyamoya Disease and Spectrums of RNF213 Vasculopathy

OY Bang, JW Chung, DH Kim, HH Won… - Translational stroke …, 2020 - Springer
Moyamoya disease (MMD) is a rare cerebrovascular disease characterized by progressive
stenosis of large intracranial arteries and a hazy network of basal collaterals called …

RNF213 loss-of-function promotes pathological angiogenesis in moyamoya disease via the Hippo pathway

F Ye, X Niu, F Liang, Y Dai, J Liang, J Li, X Wu… - Brain, 2023 - academic.oup.com
Moyamoya disease is an uncommon cerebrovascular disorder characterized by steno-
occlusive changes in the circle of Willis and abnormal vascular network development. Ring …

Predictive role of heterozygous p.R4810K of RNF213 in the phenotype of Chinese moyamoya disease

Y Wang, Z Zhang, L Wei, Q Zhang, Z Zou, L Yang, D Li… - Neurology, 2020 - AAN Enterprises
Objective Precise genetic analyses were conducted with ring finger protein 213 (RNF213) in
relation to a particular clinical phenotype in Chinese patients with moyamoya disease …